Although expression of these genes was sensitive to loss of IFT57 but not CD47 in thyroid carcinoma cells, a majority showed positive or negative coexpression with CD47 mRNA in the tumors that paralleled their IFT57 coexpression (e.g., RAMP1, Figure 6b). This evidence concerns the gene IFT57 and thyroid gland carcinoma.